The health care market is failing to support new antibiotics used to treat some of the world’s most dangerous, drug-resistant ‘superbugs,’ according to a new analysis.
New study is ‘chilling commentary’ on future of antibiotics
The health care market is failing to support new antibiotics used to treat some of the world’s most dangerous, drug-resistant ‘superbugs,’ according to a new analysis.